Chemoinformaics analysis of 3-[(E)-(1,3-Benzodioxole-5-yl)methylene]-4-piperonyltetrahydrofuran-2-one
| Molecular Weight | 352.342 | nRot | 3 |
| Heavy Atom Molecular Weight | 336.214 | nRig | 27 |
| Exact Molecular Weight | 352.095 | nRing | 5 |
| Solubility: LogS | -5.715 | nHRing | 3 |
| Solubility: LogP | 3.742 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 48.8807 |
| nHD | 0 | BPOL | 25.5993 |
| QED | 0.625 |
| Synth | 3.098 |
| Natural Product Likeliness | 0.901 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.998 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.877 |
| MDCK | 0.000024 |
| BBB | 0.043 |
| PPB | 0.997032 |
| VDSS | 0.662 |
| FU | 0.0178155 |
| CYP1A2-inh | 0.988 |
| CYP1A2-sub | 0.148 |
| CYP2c19-inh | 0.982 |
| CYP2c19-sub | 0.103 |
| CYP2c9-inh | 0.916 |
| CYP2c9-sub | 0.85 |
| CYP2d6-inh | 0.986 |
| CYP2d6-sub | 0.884 |
| CYP3a4-inh | 0.98 |
| CYP3a4-sub | 0.304 |
| CL | 17.091 |
| T12 | 0.178 |
| hERG | 0.072 |
| Ames | 0.543 |
| ROA | 0.111 |
| SkinSen | 0.595 |
| Carcinogencity | 0.891 |
| EI | 0.29 |
| Respiratory | 0.272 |
| NR-Aromatase | 0.075 |
| Antiviral | No |
| Prediction | 0.729952 |